Physician profile
Loc Dac Bui
NPI 1023081387
$3,012.43
in general payments reported to CMS, 2019-2025
19 companies · $507 in 2025
The $507 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,306 · 2021: $424 · 2022: $307 · 2023: $168 · 2024: $300 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $975.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $869.34 | 2019-2024 | Vemlidy, Epclusa |
| Bayer Healthcare Pharmaceuticals INC. | $393.70 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.12 | 2019-2021 | |
| Amarin Pharma, INC. | $210.00 | 2019 | |
| Novo Nordisk INC | $163.39 | 2021-2022 | |
| Sanofi Pasteur INC. | $127.24 | 2019 | |
| Abbott Laboratories | $125.31 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $121.36 | 2019 | |
| Abbvie INC. | $110.00 | 2019 | |
| Sumitomo Pharma America, INC. | $109.30 | 2025 | Gemtesa |
| Lilly USA, LLC | $98.81 | 2019 | |
| Redhill Biopharma INC. | $93.98 | 2025 | Talicia |
| Janssen Pharmaceuticals, INC | $80.00 | 2019 | |
| Covidien Lp | $74.26 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $62.39 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $49.03 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $34.51 | 2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $27.69 | 2023 | Venaseal |
| Mylan Specialty L.P. | $25.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loc Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.